The Agr Quorum-Sensing System Regulates Fibronectin Binding but Not Hemolysis in the Absence of a Functional Electron Transport Chain
Open accessThe DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Abstract
Staphylococcus aureus is responsible for numerous chronic and recurrent infections, which are frequently associated with the emergence of small-colony variants (SCVs) that lack a functional electron transport chain. SCVs exhibit enhanced expression of fibronectin-binding protein (FnBP) and greatly reduced hemolysin production, although the basis for this is unclear. One hypothesis is that these phenotypes are a consequence of the reduced Agr activity of SCVs, while an alternative is that the lack of a functional electron transport chain and the resulting reduction in ATP production are responsible. Disruption of the electron transport chain of S. aureus genetically ( hemB and menD ) or chemically, using 2- n -heptyl-4-hydroxyquinoline N -oxide (HQNO), inhibited both growth and Agr activity and conferred an SCV phenotype. Supplementation of the culture medium with synthetic autoinducing peptide (sAIP) significantly increased Agr expression in both hemB mutant strains and S. aureus grown with HQNO and significantly reduced staphylococcal adhesion to fibronectin. However, sAIP did not promote hemolysin expression in hemB mutant strains or S. aureus grown with HQNO. Therefore, while Agr regulates fibronectin binding in SCVs, it cannot promote hemolysin production in the absence of a functional electron transport chain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several of these phenotypes are ascribed to a combination of decreased Agr activity and enhanced SigB activity, which results in strong expression of surface proteins and an absence of cytolysin production (16, 33–35).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [35]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Update on Key Emerging Challenges in Cystic Fibrosis
Jennings, M. T., Riekert, K. A., & Boyle, M. P. (2014) · Medical Principles and Practice · doi:10.1159/000357646 · Cited by 3,648
Diep, B. A., Gill, S. R., Chang, R. F., Phan, T. H., Chen, J. H., Davidson, M. G., Lin, F., Lin, J., Carleton, H. A., Mongodin, E. F., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68231-7 · Cited by 1,633 · cited 1×
“USA300 was also employed to demonstrate that key phenotypic effects of loss of a functional electron transport chain occur in a clinically relevant strain (43).”
MethodAdhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus
Foster, T. J., Geoghegan, J. A., Ganesh, V. K., & Höök, M. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3161 · Cited by 1,533
Immune evasion by staphylococci
Foster, T. J. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1289 · Cited by 1,222
Proctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1384 · Cited by 1,175
Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule.
Novick, R. P., Ross, H. F., Projan, S. J., Kornblum, J., Kreiswirth, B., & Moghazeh, S. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06074.x · Cited by 1,072
Pathogenesis of Methicillin‐Resistant Staphylococcus aureus Infection
Gordon, R. J., & Lowy, F. D. (2008) · Clinical Infectious Diseases · doi:10.1086/533591 · Cited by 961
Quorum Sensing in Staphylococci
Novick, R. P., & Geisinger, E. (2008) · Annual Review of Genetics · doi:10.1146/annurev.genet.42.110807.091640 · Cited by 958 · cited 3×
“The phosphorylated AgrA activates the P2 promoter, thereby completing the autoinduced activation circuit (6).”
BackgroundHorsburgh, M. J., Aish, J. L., White, I. J., Shaw, L., Lithgow, J. K., & Foster, S. J. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.19.5457-5467.2002 · Cited by 699 · cited 3×
“One of the strains used in this report, SH1000, is derived from 8325 but has a repaired copy of rsbU, restoring SigB activity (42).”
BackgroundInfluentialRegulation of exoprotein gene expression in Staphylococcus aureus by agr
Recsei, P., Kreiswirth, B., O'Reilly, M., Schlievert, P., Gruss, A., & Novick, R. P. (1986) · Molecular and General Genetics MGG · doi:10.1007/bf00330517 · Cited by 618
Monk, I. R., Shah, I. M., Xu, M., Tan, M.-W., & Foster, T. J. (2012) · mBio · doi:10.1128/mbio.00277-11 · Cited by 542 · cited 1×
“hemB and menD mutations were generated using pIMAY (47), resulting”
MethodHoffman, L. R., Déziel, E., D'Argenio, D. A., Lépine, F., Emerson, J., McNamara, S., Gibson, R. L., Ramsey, B. W., & Miller, S. I. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606756104 · Cited by 467 · cited 3×
“aureus and confers an SCV-like phenotype, including slow growth and aminoglycoside resistance (45).”
BackgroundMethodPersistent and Relapsing Infections Associated with Small-Colony Variants of Staphylococcus aureus
Proctor, R. A., van Langevelde, P., Kristjansson, M., Maslow, J. N., & Arbeit, R. D. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.1.95 · Cited by 437 · cited 1×
“As their name suggests, SCVs form small colonies on agar plates, have significantly reduced hemolytic activity, and are often resistant to aminoglycoside or sulfonamide antibiotics (14, 15, 20, 24).”
BackgroundTuchscherr, L., Medina, E., Hussain, M., Völker, W., Heitmann, V., Niemann, S., Holzinger, D., Roth, J., Proctor, R. A., Becker, K., et al. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201000115 · Cited by 437 · cited 1×
“The ability of SCVs to survive in host tissues for extended periods is believed to be due, at least in part, to their ability to persist within host cells without triggering apoptosis, which shields them from immune surveillance and therapeutic antibiotics (23, 32, 33).”
BackgroundRegulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr.
Cheung, A. L., Koomey, J. M., Butler, C. A., Projan, S. J., & Fischetti, V. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6462 · Cited by 411
At the Crossroads of Bacterial Metabolism and Virulence Factor Synthesis in Staphylococci
Somerville, G. A., & Proctor, R. A. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00005-09 · Cited by 392
Herbert, S., Ziebandt, A.-K., Ohlsen, K., Schäfer, T., Hecker, M., Albrecht, D., Novick, R., & Götz, F. (2010) · Infection and Immunity · doi:10.1128/iai.00088-10 · Cited by 387
Kahl, B., Herrmann, M., Everding, A. S., Koch, H. G., Becker, K., Harms, E., Proctor, R. A., & Peters, G. (1998) · Journal of Infectious Diseases · doi:10.1086/515238 · Cited by 357 · cited 1×
“As their name suggests, SCVs form small colonies on agar plates, have significantly reduced hemolytic activity, and are often resistant to aminoglycoside or sulfonamide antibiotics (14, 15, 20, 24).”
BackgroundCheung, A. L., Eberhardt, K. J., Chung, E., Yeaman, M. R., Sullam, P. M., Ramos, M., & Bayer, A. S. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117530 · Cited by 327
Yarwood, J. M., McCormick, J. K., & Schlievert, P. M. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.4.1113-1123.2001 · Cited by 318
von Eiff, C., Heilmann, C., Proctor, R. A., Woltz, C., Peters, G., & Götz, F. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.15.4706-4712.1997 · Cited by 310
Janzon, L., & Arvidson, S. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08254.x · Cited by 296
Staphylococcus aureus Small‐Colony Variants Are Adapted Phenotypes for Intracellular Persistence
Tuchscherr, L., Heitmann, V., Hussain, M., Viemann, D., Roth, J., von Eiff, C., Peters, G., Becker, K., & Löffler, B. (2010) · The Journal of Infectious Diseases · doi:10.1086/656047 · Cited by 275 · cited 1×
“The ability of SCVs to survive in host tissues for extended periods is believed to be due, at least in part, to their ability to persist within host cells without triggering apoptosis, which shields them from immune surveillance and therapeutic antibiotics (23, 32, 33).”
BackgroundGeiger, T., Francois, P., Liebeke, M., Fraunholz, M., Goerke, C., Krismer, B., Schrenzel, J., Lalk, M., & Wolz, C. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1003016 · Cited by 243
Staphylococcus aureus Small Colony Variants in Prosthetic Joint Infection
Sendi, P., Rohrbach, M., Graber, P., Frei, R., Ochsner, P. E., & Zimmerli, W. (2006) · Clinical Infectious Diseases · doi:10.1086/507633 · Cited by 232
CodY in Staphylococcus aureus : a Regulatory Link between Metabolism and Virulence Gene Expression
Pohl, K., Francois, P., Stenz, L., Schlink, F., Geiger, T., Herbert, S., Goerke, C., Schrenzel, J., & Wolz, C. (2009) · Journal of Bacteriology · doi:10.1128/jb.01492-08 · Cited by 221
Staphylococcus aureus CcpA Affects Virulence Determinant Production and Antibiotic Resistance
Seidl, K., Stucki, M., Ruegg, M., Goerke, C., Wolz, C., Harris, L., Berger-Bächi, B., & Bischoff, M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1183-1194.2006 · Cited by 207
Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance
Oliver, A., & Mena, A. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03250.x · Cited by 194
Wlodarczyk, V., Pinabiaux, C., & Goumi, A. (2026) · HAL · doi:10.1146/annurev · Cited by 194
Pragman, A. A., Yarwood, J. M., Tripp, T. J., & Schlievert, P. M. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.8.2430-2438.2004 · Cited by 192
MDowell, P., Affas, Z., Reynolds, C., Holden, M. T. G., Wood, S. J., Saint, S., Cockayne, A., Hill, P. J., Dodd, C. E. R., Bycroft, B. W., et al. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02539.x · Cited by 190 · cited 1×
“aureus was grown in the presence of 2-n-heptyl-4-hydroxyquinoline N-oxide (HQNO) (10 g ml (1); Santa-Cruz Biotechnology) (45); synthetic type 1 AIP, as described previously (46) (1 to 10 M; Peptide Synthetics); hemin (1 g ml (1);”
Methodvon Eiff, C., Becker, K., Metze, D., Lubritz, G., Hockmann, J., Schwarz, T., & Peters, G. (2001) · Clinical Infectious Diseases · doi:10.1086/320519 · Cited by 190
Vaudaux, P., Francois, P., Bisognano, C., Kelley, W. L., Lew, D. P., Schrenzel, J., Proctor, R. A., McNamara, P. J., Peters, G., & Von Eiff, C. (2002) · Infection and Immunity · doi:10.1128/iai.70.10.5428-5437.2002 · Cited by 183 · cited 2×
“, which lacked production of RNAIII, was unusual in that it did not display enhanced fnb transcript or fibronectin-binding relative to the parent strain (36).”
BackgroundKinkel, T. L., Roux, C. M., Dunman, P. M., & Fang, F. C. (2013) · mBio · doi:10.1128/mbio.00696-13 · Cited by 179
Peacock, S. J., Day, N., Thomas, M. G., Berendt, A. R., & Foster, T. J. (2000) · Journal of Infection · doi:10.1053/jinf.2000.0657 · Cited by 178 · cited 1×
“plasma fibronectin was determined as described previously (50, 51).”
MethodJakubovics, N. S., Strömberg, N., Van Dolleweerd, C. J., Kelly, C. G., & Jenkinson, H. F. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04495.x · Cited by 170 · cited 1×
“plasma fibronectin was determined as described previously (50, 51).”
MethodEdwards, A. M., Potts, J. R., Josefsson, E., & Massey, R. C. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000964 · Cited by 164 · cited 1×
“sorbance (A595) measurement using a microplate reader, and the values were converted to bacterial numbers by the use of standard plots (52).”
MethodSelf-citationWesson, C. A., Liou, L. E., Todd, K. M., Bohach, G. A., Trumble, W. R., & Bayles, K. W. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5238-5243.1998 · Cited by 155
Physiology and Antibiotic Susceptibility of Staphylococcus aureus Small Colony Variants
Baumert, N., von Eiff, C., Schaaff, F., Peters, G., Proctor, R. A., & Sahl, H.-G. (2002) · Microbial Drug Resistance · doi:10.1089/10766290260469507 · Cited by 130 · cited 1×
“The loss of menaquinone or heme production results in loss of the electron transport chain, leading to decreased membrane potential and reduced ATP production and growth rate (20, 30, 31).”
BackgroundFenno, J. C., Hannam, P. M., Leung, W. K., Tamura, M., Uitto, V.-J., & McBride, B. C. (1998) · Infection and Immunity · doi:10.1128/iai.66.5.1869-1877.1998 · Cited by 127 · cited 2×
“sentially as described previously (54).”
MethodChatterjee, I., Kriegeskorte, A., Fischer, A., Deiwick, S., Theimann, N., Proctor, R. A., Peters, G., Herrmann, M., & Kahl, B. C. (2008) · Journal of Bacteriology · doi:10.1128/jb.00912-07 · Cited by 126
Saravia-Otten, P., Müller, H. P., & Arvidson, S. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.17.5259-5263.1997 · Cited by 122
Staphylococcus aureus α-toxin induces apoptosis in endothelial cells
Menzies, B. E., & Kourteva, I. (2000) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2000.tb01503.x · Cited by 118
Small colony variants (SCVs) of Staphylococcus aureus – A bacterial survival strategy
Kahl, B. C. (2014) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2013.05.016 · Cited by 118 · cited 1×
“As their name suggests, SCVs form small colonies on agar plates, have significantly reduced hemolytic activity, and are often resistant to aminoglycoside or sulfonamide antibiotics (14, 15, 20, 24).”
BackgroundMoisan, H., Brouillette, E., Jacob, C. L., Langlois-Bégin, P., Michaud, S., & Malouin, F. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.1.64-76.2006 · Cited by 116
Lannergård, J., von Eiff, C., Sander, G., Cordes, T., Seggewiβ, J., Peters, G., Proctor, R. A., Becker, K., & Hughes, D. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00668-08 · Cited by 108
Bates, D. M., Eiff, C. V., McNamara, P. J., Peters, G., Yeaman, M. R., Bayer, A. S., & Proctor, R. A. (2003) · The Journal of Infectious Diseases · doi:10.1086/374642 · Cited by 106
Roux, A., Todd, D. A., Velázquez, J. V., Cech, N. B., & Sonenshein, A. L. (2014) · Journal of Bacteriology · doi:10.1128/jb.00128-13 · Cited by 100
SigB Is a Dominant Regulator of Virulence in Staphylococcus aureus Small-Colony Variants
Mitchell, G., Fugère, A., Pépin Gaudreau, K., Brouillette, E., Frost, E. H., Cantin, A. M., & Malouin, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065018 · Cited by 97 · cited 1×
“In a sigB mutant defective in menaquinone biosynthesis, Agr activity was significantly elevated, providing convincing evidence that regulation by SigB, rather than low growth density, is responsible for decreased activity of Agr in bacteria lacking the electron transport chain (67).”
BackgroundBesier, S., Ludwig, A., Ohlsen, K., Brade, V., & Wichelhaus, T. A. (2007) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2007.02.003 · Cited by 94
McAdam, P. R., Holmes, A., Templeton, K. E., & Fitzgerald, J. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024301 · Cited by 94
Sadowska, B., Bonar, A., Eiff, C., Proctor, R. A., Chmiela, M., Rudnicka, W., & Róźalska, B. (2002) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2002.tb00553.x · Cited by 92 · cited 1×
“The ability of SCVs to survive in host tissues for extended periods is believed to be due, at least in part, to their ability to persist within host cells without triggering apoptosis, which shields them from immune surveillance and therapeutic antibiotics (23, 32, 33).”
BackgroundShompole, S., Henon, K. T., Liou, L. E., Dziewanowska, K., Bohach, G. A., & Bayles, K. W. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03618.x · Cited by 85 · cited 1×
“In addition to quorum sensing, there is also evidence that Agr acts as a diffusion-sensing system to signal bacterial uptake into host cell vacuoles (8).”
BackgroundNina, H., Block, D., Bianconi, I., Bragonzi, A., Birtel, J., Lee, J. C., Dübbers, A., Küster, P., Janina, K., Peters, G., et al. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.09.012 · Cited by 84
Phenotype Switching Is a Natural Consequence of Staphylococcus aureus Replication
Edwards, A. M. (2012) · Journal of Bacteriology · doi:10.1128/jb.00948-12 · Cited by 83
Self-citationSeggewiß, J., Becker, K., Kotte, O., Eisenacher, M., Yazdi, M. R. K., Fischer, A., McNamara, P., Al Laham, N., Proctor, R., Peters, G., et al. (2006) · Journal of Bacteriology · doi:10.1128/jb.00774-06 · Cited by 82 · cited 1×
“The loss of menaquinone or heme production results in loss of the electron transport chain, leading to decreased membrane potential and reduced ATP production and growth rate (20, 30, 31).”
BackgroundDean, M. A., Olsen, R. J., Long, S. W., Rosato, A. E., & Musser, J. M. (2014) · Infection and Immunity · doi:10.1128/iai.01487-13 · Cited by 69
Seifert, H., von Eiff, C., & Fätkenheuer, G. (1999) · Emerging Infectious Diseases · doi:10.3201/eid0503.990319 · Cited by 68
Abele-Horn, M., Schupfner, B., Emmerling, P., Waldner, H., & Göring, H. (2000) · Infection · doi:10.1007/s150100050014 · Cited by 65
Sreeramoju, P., Porbandarwalla, N. S., Arango, J. I., Latham, K. P., Dent, D. L., Stewart, R. M., & PATTERSON, J. E. (2010) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2009.12.024 · Cited by 61
Lattar, S. M., Tuchscherr, L. P. N., Caccuri, R. L., Centrón, D., Becker, K., Alonso, C. A., Barberis, C. M., Miranda, G., Buzzola, F. R., von Eiff, C., et al. (2009) · Infection and Immunity · doi:10.1128/iai.01214-08 · Cited by 55
Rivera, F. E., Miller, H. K., Kolar, S. L., Stevens, S. M., & Shaw, L. N. (2012) · PROTEOMICS · doi:10.1002/pmic.201100298 · Cited by 53
Pragman, A. A., Ji, Y., & Schlievert, P. M. (2006) · Biochemistry · doi:10.1021/bi0603266 · Cited by 48
Update on methicillin-resistant Staphylococcus aureus in cystic fibrosis
Dasenbrook, E. C. (2011) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32834b95ed · Cited by 43
James, E., Edwards, A. M., & Wigneshweraraj, S. (2013) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12309 · Cited by 42 · cited 12×
“RNA extraction and real-time (RT) PCR were performed as described previously (44).”
BackgroundMethodResultSelf-citationSmall-colony variants of Staphylococcus aureus.
Looney, W. J. (2000) · PubMed · Cited by 40
σ B Activity in a Staphylococcus aureus hemB Mutant
Senn, M. M., Bischoff, M., von Eiff, C., & Berger-Bächi, B. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.21.7397-7406.2005 · Cited by 39
Proctor, R. A., Dalal, S. C., Kahl, B. C., Brar, D. W., Peters, G., & Nichols, W. W. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2333-2336.2002 · Cited by 29 · cited 1×
“showed that chemical inhibition of the electron transport chain abrogated hemolysin production (41).”
BackgroundMolecular Analysis of Repeated Methicillin-Resistant Staphylococcus aureus Infections in Children
Chen, C., Su, L., Lin, T., & Huang, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014431 · Cited by 25
Peyrani, P., Allen, M., Seligson, D., Roberts, C., Chen, A., Haque, N. Z., Zervos, M. J., Wiemken, T. L., Harting, J., Christensen, D. M., et al. (2012) · PubMed · Cited by 16
SMALL COLONY VARIANT STAPHYLOCOCCUS AUREUS MULTIORGAN INFECTION
Agarwal, H., Verrall, R., Singh, S. P., Tang, Y.-W., & Wilson, G. (2007) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000256749.29244.67 · Cited by 12
Barbero (2014) · doi:10.1016/j · Cited by 1
Cited by
Kahl, B. C., Becker, K., & Löffler, B. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00069-15 · Cited by 325
Painter, K. L., Krishna, A., Wigneshweraraj, S., & Edwards, A. M. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.09.002 · Cited by 181
Self-citationPainter, K. L., Strange, E., Parkhill, J., Bamford, K. B., Armstrong-James, D., & Edwards, A. M. (2015) · Infection and Immunity · doi:10.1128/iai.03016-14 · Cited by 153
“USA300-derived hemB and menD mutants (35) were complemented”
BackgroundSelf-citationStaphylococcus aureus inactivates daptomycin by releasing membrane phospholipids
Pader, V., Hakim, S., Painter, K. L., Wigneshweraraj, S., Clarke, T. B., & Edwards, A. M. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.194 · Cited by 142
Self-citationZeden, M. S., Schuster, C. F., Bowman, L., Zhong, Q., Williams, H. D., & Gründling, A. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.818716 · Cited by 108
Metadata
- Authors
- Pader, V., James, E. H., Painter, K. L., Wigneshweraraj, S., & Edwards, A. M.
- Affiliations
- Imperial College London (GB)
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2014-10
- Volume
- 82
- Issue
- 10
- Pages
- 4337-4347
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- PMC
- PMC4187888
- OpenAlex
- W2162260373
- Cited by
- 32
- References
- 71
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 4 · 2022: 2 · 2020: 3 · 2019: 3 · 2018: 5 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 2
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Infection and Immunity (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (100958/Z/13/Z, 100958)
- Medical Research Council (MR/J006874/1)
- Biotechnology and Biological Sciences Research Council (BB/I001492/1)
- National Institute of Allergy and Infectious Diseases (HHSN272200700055C)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- Staphylococcus aureus, agr quorum sensing, small colony variants, electron transport chain, fibronectin binding, fibronectin-binding protein, hemolysin, MenD, 2-n-heptyl-4-hydroxyquinoline-N-oxide, bacterial adhesion, chronic infection
- MeSH terms
- Bacterial Proteins, Electron Transport, Fibronectins, Hemolysis, Humans, Protein Binding, Staphylococcus aureus, Trans-Activators, Quorum Sensing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.